The COVID-19 Pandemic as a threatening for bone health

Main Article Content

Eirini Kotsalou
Athanasios Zafeirakis
Evaggelia Kotsalou


The worldwide predominance of coronavirus disease 2019 (COVID-19) pandemic will have tremendous consequences on bone health of the general population and specifically to the bone mineral density of both young and elderly adolescents, due to sedentary lifestyle resulting from the prolonged and repeated lockdown. Scientific articles argue about the short and long term consequences on bone health resulting from the social isolation and the subsequent sedentary behaviors, whereas experts focus their scientific interest at guidelines for diagnosis, management and prevention of osteoporosis in the era of the COVID-19 pandemic


Download data is not yet available.

Article Details

How to Cite
Kotsalou, E., Zafeirakis, A., & Kotsalou, E. (2021). The COVID-19 Pandemic as a threatening for bone health. Medical Science and Discovery, 8(3), 143-146.
Review Article


1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.

2. Stanton R, Khalesi, S, Williams SL, Alley SJ, Thwaite TL, Fenning AS, Vandelanotte C. Depression, anxiety and stress during COVID-19: Associations with changes in physical activity, sleep, tobacco and alcohol use in Australian adults. Int J Environ Res Public Health. 2020 Jun; 17(11): 4065. Published online 2020 Jun 7. doi: 10.3390/ijerph17114065

3. Lesser, I.A.; Nienhuis, C.P. The impact of COVID-19 on physical activity behavior and well-being of Canadians. Int J Environ Res Public Health. 2020 May 31;17(11):3899. doi: 10.3390/ijerph17113899

4. Survey EI, Ammar A, Brach M, Trabelsi K, Chtourou H, Boukhris O et al. Effects of COVID-19 home confinement on eating behaviour and physical activity: Results of the ECLB-COVID19 international online survey. Nutrients. 2020 May 28;12(6):1583. doi: 10.3390/nu12061583.

5. Lippi G, Henry BM, Bovo C, Sanchis-Gomar F. Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19). Diagnosis (Berl). 2020 May 26;7(2):85-90. doi: 10.1515/dx-2020-0041.

6. Zheng C, Yajun Huang W, Sinead Sheridan, Cindy Hui-Ping Sit, Xiang-Ke Chen, Stephen Heung-Sang Wong. COVID-19 Pandemic Brings a Sedentary Lifestyle in Young Adults: A Cross-Sectional and Longitudinal Study. Int J Environ Res Public Health. 2020 Aug 19;17(17):6035. doi: 10.3390/ijerph17176035.

7. Yuji Yokozeki, Kentaro Uchida, Masayuki Miyagi, Kosuke Murata, Tomohisa Koyama, Akiyoshi Kuroda, et al. Short-Term Impact of Staying Home on Bone Health in Patients With Osteoporosis During a State of Emergency Declaration Due to COVID-19 in Kanagawa, Japan. Cureus. 2020 Sep; 12(9): e10278. doi: 10.7759/cureus.10278.

8. Solbakken SM, Magnus JH, Meyer HE, Emaus N, Tell GS, Holvik K, et al. Impact of comorbidity, age, and gender on seasonal variation in hip fracture incidence. A NOREPOS study. Arch Osteoporos. 2014;9:191. doi: 10.1007/s11657-014-0191-2. Epub 2014 Aug 19.

9. Yu EW, Tsourdi E, Clarke BL, Bauer DC, Drake MT. Osteoporosis Management in the Era of COVID-19. J Bone Miner Res.2020;10.1002/jbmr.4049. doi:10.1002/jbmr.4049.

10. Nanduri AP, Fullman S, Morell L, Buyske S, Wagner ML. Pilot study for implementing an osteoporosis education and exercise program in an assisted living facility and senior community. J Appl Gerontol. 2018 Jun;37(6):745–762. doi: 10.1177/0733464816672045. Epub 2016 Oct 11.

11. Watson SL, Weeks BK, Weis LJ, Harding AT, Horan SA, Beck BR. High-intensity resistance and impact training improves bone mineral density and physical function in postmenopausal women with osteopenia and osteoporosis: the LIFTMOR randomized controlled trial. J Bone Miner Res. 2018 Feb;33(2):211-220. doi: 10.1002/jbmr.3284. Epub 2017 Oct 4.

12. Papaioannou A, Adachi JD, Winegard K, Ferko N, Parkinson W, Cook RJ, Webber C, McCartney N. Efficacy of home-based exercise for improving quality of life among elderly women with symptomatic osteoporosis-related vertebral fractures. Osteoporos Int. 2003 Aug;14(8):677–682. doi: 10.1007/s00198-003-1423-2. Epub 2003 Jul 22

13. Ogliari G, Lunt E, Ong T, Marshall L, Sahota O. The impact of lockdown during the COVID-19 pandemic on osteoporotic fragility fractures: an observational study. Archives of Osteoporosis. 2020 ;15:156. (ISI-Indexed)

14. Kelsey JL, Berry SD, Procter-Gray E, Quach L, Nguyen USDT, Li W, et al. Indoor and outdoor falls in older adults are different: the maintenance of balance, independent living, intellect, and Zest in the Elderly of Boston Study. J Am Geriatr Soc. 2010 Nov;58(11):2135–41. doi: 10.1111/j.1532-5415.2010.03062.x. Epub 2010 Sep 9.

15. Babatsikou F, Kotsalou I, Koutis C. Falls in elderly population: Epidemiology, causes and preventive interventions. Review of Clinical Pharmacology and Pharmacokinetics, International Edition. 2018 Feb;32(2):91-99.

16. Launonen AP, Lepola V, Saranko A, Flinkkilä T, Laitinen M, Mattila VM Epidemiology of proximal humerus fractures. Arch Osteoporos. 2015;10:209. doi: 10.1007/s11657-015-0209-4. Epub 2015 Feb 13.

17. Kanis JA, Oden A, Johansson H, Borgström F, Ström O, McCloskey E. FRAX and its applications to clinical practice. Bone. 2009 May;44(5):734–43. doi: 10.1016/j.bone.2009.01.373. Epub 2009 Feb 3.

18. Li YT, Cai HF, Zhang ZL. Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and metaanalysis of randomized control trials. Osteoporosis Int. 2015 Feb;26(2):431-41. doi: 10.1007/s00198-014-2903-2. Epub 2014 Sep 30.

19. Popp AW, Senn R, Curkovic I, Senn C, Buffat H, Popp PF, Lippuner K. Factors associated with acute-phase response of bisphosphonate-naive or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate. Osteoporos Int. 2017 Jun; 28(6):1995–2002. doi: 10.1007/s00198-017-3992-5. Epub 2017 Mar 15.

20. Crotti C, Watts NB, De Santis M, Ceribelli A, Fabbriciani G, Cavaciocchi F et al. Acute phase reactions after zoledronic acid infusion: protective role of 25-hydroxyvitamin D and previous Oral bisphosphonate therapy. Endocr Pract. 2018 May; 24(5):405-410. PubMed ID 29498910.

21. Dennison EM, Cooper C, Kanis JA, Bruyere O, Silverman S, McCloskey E et al. Fracture risk following intermission of osteoporosis therapy. Osteoporos Int. 2019 Sep;30(9):1733-1743. doi: 10.1007/s00198-019-05002-w. Epub 2019 Jun 7.

22. Barrionuevo P, Gionfriddo MR, Castaneda-Guarderas A, Zeballos Palacios C, Bora P, Mohammed K, et al. Women’s values and preferences regarding osteoporosis treatments: a systematic review. J Clin Endocrinol Metab. 2019 May;104(5):1631–1636.

23. Spiezia L, Boscolo A, Poletto F, et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost. 2020 Jun;120(6):998-1000. doi: 10.1055/s-0040-1710018. Epub 2020 Apr 21.

24. Cobin RH, Goodman NF, AACE Reproductive Endocrinology Scientific Committee. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on menopause: 2017 update. Endocr Pract. 2017 Jul;23(7):869-80. doi: 10.4158/EP171828.PS.

25. Diker-Cohen T, Rosenberg D, Avni T, Shepshelovich D, Tsvetov G, Gafter-Gvili A. Risk for infections during treatment with denosumab for osteoporosis: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2020 May 1;105(5):dgz322. doi: 10.1210/clinem/dgz322.

26. Girgis CM, Clifton-Bligh RJ, Osteoporosis in the age of COVID-19. Osteoporos Int. 2020 Jul;31(7):1189-1191. doi: 10.1007/s00198-020-05413-0. Epub 2020 Apr 28

27. Watson SL, Weeks BK, Weis LJ, Harding AT, Horan SA, Beck BR. High-intensity resistance and impact training improves bone mineral density and physical function in postmenopausal women with osteopenia and osteoporosis: the LIFTMOR Randomized Controlled Trial. J Bone Miner Res. 2018 Feb;33(2):211-220. doi: 10.1002/jbmr.3284. Epub 2017 Oct 4.

28. Gittoes NJ, Criseno S, Appelman-Dijkstra NM, et al. Endocrinology in the time of COVID-19: Management of calcium disorders and osteoporosis. Eur J Endocrinol. 2020 Aug;183(2):G57-G65. doi: 10.1530/EJE-20-0385.

29. Formenti AM, Pedone E, Filippo L, Ulivieri FM, Giustina A. Are women with osteoporosis treated with denosumab at risk of severe COVID-19? Endocrine. 2000;70(2).

30. Napoli N, Elderkin AL, Kiel DP, Khosla S. Managing fragility fractures during the COVID-19 pandemic. Nat Rev Endocrinol. 2020 Sep;16(9):467-468. doi: 10.1038/s41574-020-0379-z.

31. Chen P, Mao L, Nassis GP, Harmer P, Ainsworth BE, Li F. Coronavirus disease (COVID-19): the need to maintain regular physical activity while taking precautions. J Sport Health Sci. 2020 Mar; 9(2): 103–104. doi: 10.1016/j.jshs.2020.02.001

32. Bull FC, et al. World Health Organization 2020 guidelines on physical activity and sedentary behavior. Br J Sports Med. 2020 Dec;54(24):1451-1462. doi: 10.1136/bjsports-2020-102955.